Abstract
INTRODUCTION
Colorectal cancer (CRC) is one of the most common digestive malignancies in the world [1] . With the devel opment of new technology in CRC diagnosis and treat ment, the prognosis of patients with early detection has been improved. However, the overall 5year survival rate in advanced cases remains poor [2] . In the United States, CRC was the fourth most common malignant tumor, with 135430 new cases and 50260 deaths in 2017 [3] . There fore, specific CRC biomarkers and therapeutic pathways are in great need to improve the prognosis for patients.
Noncoding RNAs, including microRNAs (miRNAs) and longnoncoding RNAs (lncRNAs), can regulate onco gene and tumor suppressor gene expression in multiple ways [4, 5] . MiRNAs are 2022 nucleotides long and regulate genes posttranscriptionally by directly binding mRNAs [6] . LncRNAs are defined as transcripts that range from 200 nucleotides to multiple kilobases in length [7] . Recent research has focused on these lncRNAs, which function as competing endogenous RNAs (ceRNAs) to regulate gene expression by sponging miRNAs through shared miRNA response elements [8] .
In the last few years, with the development of gene sequencing technology, dysregulation of lncRNAs has been revealed in diverse malignancies. Studies have utilized bioinformatics tools to predict the target genes of novel lncRNAs, and molecular biology techniques including real time quantitative polymerase chain re action (RTqPCR), silencing technique, and luciferase reporter gene assays, among others, to validate in silico predictions. In CRC, the lncRNA UICLM acts as a ceRNA for hsamiR215 to upregulate ZEB2 expression and promote CRC progression [9] . Additionally, the lncRNA HNF1AAS1 functions as an oncogene in the metastasis of CRC by modulating the hsamiR34/p53 axis [10] . Final ly, the lncRNA CASC2 plays a role as a tumor suppressor gene by sponging hsamiR18a [11] . The lncRNA/miRNA/mRNA axis is regarded as an important mechanism in tumor progression and meta stasis [12] . However, studies of ceRNA networks of novel coding and noncoding RNAs in CRC in large cohorts have not been performed. In our study, we obtained malignant and normal tissue expression profiles from The Cancer Genome Atlas (TCGA, http://cancergenome.nih.gov) project [13] . CeRNA networks were constructed including differentially expressed mRNAs (DEmRNAs), differentially expressed lncRNAs (DElncRNAs), and differentially expressed miRNAs (DEmiRNAs), which were based on the miRcode (http://www.mircode.org/) [14] , miRTarBas (http://mirtarbase.mbc.nctu.edu.tw/php/) [15] , TargetScan (http://www.targetscan.org/), and miRDB (http:// www.mirdb.org/) databases [16] . KaplanMeier survival curve analysis was performed to identify differentially expressed genes (DEGs) that are associated with overall survival.
MATERIALS AND METHODS

Sample collection
We downloaded CRC transcriptome profiles from TCGA through the Genomic Data Commons (GDC) Data Trans fer Tool 1.3.0 [13] . The public data included the tissue expression profiles (derived by RNAseq) of 644 CRC tissues and 51 normal tissues (level 3) and 619 CRC and 11 normal tissue expression profiles (level 3) derived by miRNAseq. According to the publication guidelines (2015) provided by TCGA (https://cancergenome.nih. gov/publications/publicationguidelines), our study does not require the approval of an ethics committee.
Identification of DEGs
We analyzed the RNAseq data by merging it to an RNA matrix with PERL software. Then, we converted the gene ID to gene name according to Ensembl (Homo sapiens) (http://asia.ensembl.org/index.html). The miRNAseq data were analyzed using the same method. DEmRNAs, DElncRNAs, and DEmiRNAs were identified with the edgeR package in R with a threshold log2 fold change (FC) > 2.0 and P < 0.01. Heat maps of DEGs were constructed using the gplots package in R.
Functional analysis and ceRNA network construction
Next, we constructed ceRNA networks that were mapped by identifying DEGs to an established coexpression data base (miRcode, miRTarBase, TargetScan, and miRDB). LncRNAmiRNAmRNA reactions were split into lncRNA miRNA and miRNAmRNA interactions. LncRNAmiRNA interactions were predicted by comparing DElncRNAs and DEmiRNAs to the miRcode database. DEmRNAs regulating genes of DEmiRNAs were identified by inter secting the predicted results between miRTarBase, TargetScan, and the miRDB databases. According to the ceRNA hypothesis [12] , miRNAs negatively regulate mRNA expression and lncRNAs act as ceRNAs to limit miRNA function by sponging them. The networks were visualized and mapped using Cytoscape v3.5.1 [17] .
To explore the function of the DEGs in the ceRNA networks in tumorigenesis and metastasis, KEGG path ways [18] were analyzed using KOBAS (http://kobas. cbi.pku.edu.cn/), which is a web server that annotates an input set of genes with pathways based on human disease databases [19] . Then, we utilized STRING protein database v10.5 (http://stringdb.org/) to analyze the proteinprotein interactions of the DEGs.
Association analysis between DEGs and CRC patient survival
We selected CRC adenocarcinoma and adjacent nor mal tissue expression data and clinical information from TCGA project. None of the patients received pre operative treatment. KaplanMeier survival analysis and the logrank test were performed for DEGs in the ceRNA networks. P < 0.05 was regarded as statistically signifi cant.
Cell lines and cell culture
The CRC cell lines HT29, LoVo, and SW480, along with the normal intestinal epithelial cell line NCM460, were purchased from the Institute of Biochemistry and Cell Biology at the Chinese Academy of Sciences, Shanghai, China. The cell lines were cultured in RPMI 1640 medium (HyClone, Logan, UT, United States) supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY, United States), 100 U/mL penicillin, and 100 μg/mL strep tomycin. All cells were maintained in an incubator with a humidified atmosphere of 95% air and 5% CO2 at 37 ℃.
DElncRNA detection
Total RNA was isolated from the cells using Trizol reagent (Invitrogen, Carlsbad, CA, United States). The quality and concentration of isolated RNA were detected with a NanoDrop 2000 spectrophotometer. Total RNA (800 ng) was converted to cDNA by using the PrimeScript TM RT reagent Kit (Takara, Otsu, Shiga, Japan). The Kit contained gDNA Eraser which could remove genomic DNA. We utilized LightCycler96 (Roche Diagnostic, Basel, Switzerland) to perform RTqPCR using SYBR Green (Takara). The twostep amplification reaction was as follows: 95 ℃ for 30 s for preincubation, then 45 cycles of 95 ℃ for 10 s and 60 ℃ for 30 s. GAPDH expression was used as an endogenous control. Quantitative ana lysis was calculated using the 2 ΔΔCt method [20] . Primers were designed as follows: POU6F2AS2 forward, 5'ACAGCAGTGCCAGAAGGAGTATTG3' and reverse, 5'GCAGACCTGAGCTTGTGAGTGAC3'; LINC00488 forward, 5'GAGCAGCAAGAATGAGAGCAGAGG3' and reverse, 5'GAATCTGAGGAAGCACCGTGAACC3'; IGF2 AS forward, 5'TCCACACCAGACAGCACAGACC3' and reverse, 5'TCCGTGGTTGGCTCCAGGTG3'; GAPDH forward, 5'AGCCACATCGCTCAGACAC3' and reverse, 5'GCCCAATACGACCAAATCC3'.
Statistical analysis
All data were analyzed using SPSS 20.0 (Chicago, IL, United States). Student's ttest was performed for CRC cell lines and normal intestinal epithelial cell line com parisons. Differences with P < 0.05 were regarded as statistically significant. All experiments were repeated three times.
RESULTS
Identification of DEGs in CRC
We identified DElncRNAs and DEmRNAs between 644 CRC and 51 normal tissue expression profiles from TCGA. As a result, we identified 1043 DElncRNAs, 2146 DEmRNAs, and 276 DEmiRNAs using the edgeR pack age in R. There were 768 upregulated and 275 down regulated DEGs among the DElncRNAs, and 1198 upregulated and 948 downregulated DEGs in the DEmRNAs. Using the same method, 180 upregulated and 96 downregulated DEmiRNAs were obtained by comparing 619 CRC and 11 normal tissue expression profiles. Moreover, we constructed heat maps of the top DEGs (log2 FC > 5, P < 0.01) in each category using R (Figures 13).
Construction of ceRNA networks
To construct the ceRNA networks, we predicted the inter actions among DEGs using online bioinformatics tools. We utilized miRcode to predict the interactions between DElncRNAs and DEmiRNAs and we also predicted DEmRNAs targeted by the DEmiRNAs by intersecting the predictions of miRTarBase, TargetScan, and miRDB ( Figure 4 ). Ultimately, 81 DElncRNAs, 20 DEmiRNAs, and 54 DEmRNAs were identified to construct the ceRNA networks of CRC using Cytoscape ( Figure 5 ). The interactions among DEGs are shown in Tables 1 and 2 .
Functional analysis of DEmRNAs in ceRNA networks
To better reveal the function of ceRNA networks in CRC, we subjected the 54 DEmRNAs in the ceRNA net works to Kyoto Encyclopedia of Genes and Genomes CST1  KRT80  FOXQ1  MMP7  KRT23  CEL  NOTUM  KLK6  LEMD1  TCN1  DUSP27  AQP8  CA1  TMIGD1  SFTA2  CST2  DKK4  SPERT  KRT75  SERPINA4  ORM2  CST4  KLK7  KLK8  C6orf15  PPBP  SLCO1B3  EN2  SOX14  ELF5  MUC6  CLDN18  SLC26A9  PAEP  HABP2  HIST1H1E  HIST1H1B  HIST1H4C  hP  ONECUT3  ZIC2  ZIC5  FEZF1  FGA  FGB  AHSG  ORM1  EPYC  IGFL1  PRSS56  OBP2B  PNMA5  C14orf105  C8orf74  HIST1H4B  HIST1H2BI  OTOP2  MS4A10  APOA4  SLC10A2  HIST1H4L  HIST1H2BB  SPRR2E  IVL  HRG  CRP  GC  C8A  MAGEA11  MAGEA3  MAGEA6  CSAG1  MAGEA12  ALB  FGL1  VGLL1  KLK5  SPRR2D  SPRR2A  SPRR1A  SPRR1B  SPRR3  NKX2-1  MT4  PRR9  KRT31  FGG  MAGEA4  MAGEA10  MAGEA1  MAGEC1 Value (KEGG) pathway analysis using KEGG Orthology Based Annotation System (KOBAS) 3.0, and the top ten KEGG pathways are shown in Table 3 . There were nine path ways related to cancer, including "Colorectal cancer", "p53 signaling pathway", "Chronic myeloid leukemia", "Proteoglycans in cancer", "miRNAs in cancer", "Thyroid cancer", "Transcriptional misregulation in cancer", "Pathways in cancer", and "Wnt signaling pathway". These results indicate that ceRNA networks play impor tant roles in the carcinogenesis and progression of CRC.
DEGs related with prognosis of CRC patients
We preformed KaplanMeier curve analysis to identify the DEGs in the ceRNA networks that are related to overall survival. The results showed that 3 DElncRNAs (IGF2AS, POU6F2AS2, and LINC00488), 3 DEmiRNAs (hsamiR32, hsamiR141, and hsamiR375), and 2 DEmRNAs (PHLPP2 and SERPINE1) were associated with the clinical prognosis of patients. The KaplanMeier curves showed that the lncRNAs IGF2AS and POU6F2 AS2, as well as hsamiR32, hsamiR141, and serpin peptidase inhibitor, clade E member 1 (SERPINE1) were negatively correlated with overall survival, whereas LINC00488, hsamiR375, and PH domain and leucine rich repeat protein phosphatase 2 (PHLPP2) were positively correlated with overall survival (Figure 6 ). The ceRNA networks illustrated that PHLPP2 may be regulated by hsamiR32 and hsamiR141. Interestingly, PHLPP2 as well as hsamiR32 and hsamiR141 has been previously related to patient prognosis. We used The target genes of the differentially expressed microRNAs were predicted with three online databases (TargetScan, miRDB, and miRTarBase).
DEmiRNAs DElncRNAs DEmiRNAs DElncRNAs
Hsa- miR193b   IGF2-AS, H19, MIR31HG, WT1-AS, MUC19, UCA1,  POU6F2-AS1, TSSC1-IT1, MRPL23-AS1, SPATA13-AS1, HOTAIR, WASIR2, DLX6-AS1, CRNDE, (Figure 7 ).
Expression of IGF2-AS, POU6F2-AS2, and LINC00488 in cell lines
To further confirm our in silico results, we performed RTqPCR to detect the expression levels of IGF2AS, POU6F2AS2, and LINC00488 in CRC cell lines (HT29, LoVo, and SW480) and in a normal intestinal epithelial cell line (NCM460). We found that the expression of IGF2 AS and POU6F2AS2 was significantly increased in CRC cell lines. Conversely, LINC00488 was downregulated in CRC cell lines compared with NCM460 ( Figure 8 ).
DISCUSSION
The role of ceRNAs in tumorigenesis and development has remained controversial [21] . However, many studies have revealed the regulatory function of ceRNA networks in proliferation, invasion, metastasis, and epithelial mesenchymal transition (EMT). This urgently requires the establishment of a comprehensive regulatory net work based on a large sample size of whole genome sequences. By constructing regulatory networks, we can better clarify the role of ceRNAs and provide direction for further research.
In this study, we integrated lncRNA, miRNA, and mRNA highthroughput data from TCGA and constructed ceRNA networks. KEGG pathway analysis of DEmRNAs indicated that ceRNA networks may regulate CRC pro gression via multiple mechanisms. It is noteworthy that "Colorectal cancer" was the most significant pathway in which transcription factor 7 (TCF7), cyclin D1 (CCND1), and transforming growth factor, beta 2 (TGFB2) are involved. TCF7 is a critical signaling molecule in the WNT/βcatenin pathway, which belongs to the TCF/LEF1 family [22] . The WNT/βcatenin pathway is recognized as a key regulator in cancer by transcriptionally activating a va riety of oncogenes including CCND1 [23] . CCND1 has been validated as an oncogene in CRC, and it regulates the cell cycle transition from the G1 phase to the S phase [24] . Chen et al [25] showed that TGFB2 induces CRC migration, metastasis, and the EMT by promoting SNAIL and SLUG expression.
To identify novel prognosisrelated biomarkers, we applied KaplanMeier curve analysis to identify DEGs in ceRNA networks that correlated with clinical fea tures among CRC patients. Ultimately, we detected 3 DEmiRNAs (hsamiR32, hsamiR141, and hsa miR375), and 2 DEmRNAs (PHLPP2 and SERPINE1) that may be indicators of prognosis. Wu et al [26] showed that hsamiR32 promoted CRC growth, migration, and invasion by downregulating PTEN. Feng et al [27] revealed that hsamiR141 may act as a biomarker for the early detection of recurrence during CRC surveillance. Cui et al [28] found that hsamiR375 acts as an antioncogene through the inhibition of SP1, BCL2, and other EMT associated genes. Increased SERPINE1 expression has been found in G3/G4 CRC cells, which may be a predictor of CRC invasiveness, progression, and overall survival [29] . PHLPP2, a protein phosphatase, is an isoform of PHLPP. PHLPP2 negatively regulates RAF/MEK/ERK signaling by directly inhibiting RAF1 activity to inhibit the progression of cancer [30] . Li et al [31] and Liao et al [32] reported that hsa miR938 and hsamiR224 repressed PHLPP2 expression in CRC. In the ceRNA networks identified here, our prediction showed that PHLPP2 is targeted by hsa miR141, hsamiR32, and hsamiR424. We noted that the hsamiR141/PHLPP2 and hsamiR32/PHLPP2 axis in ceRNA networks may be a diagnostic biomarker and a therapeutic target for the treatment of CRC.
In the present study, 1043 DElncRNAs were detected in 644 CRC tissues compared to 51 normal tissues. Among them, 3 DElncRNAs (IGF2AS, POU6F2AS2, and LINC00488) were related to the prognosis of CRC. The lncRNA IGF2AS is an antisense lncRNA for IGF2, and has been validated to promote hepatitis C virus replication [33] . In our work, IGF2AS may regulate target genes by competitive sponging against hsamiR150 and hsamiR193b. The lncRNA POU6F2AS2 has been demonstrated to be overexpressed in esophageal squa mous cell cancer, which can directly target the Ybx pro tein and protect cancer cells from ionizing radiation [34] . We predicted that hsamiR375 interacts with POU6F2 AS2, which is related with clinical prognosis. Additionally, hsamiR375 is related to overall survival. The POU6F2 AS2/hsamiR375 axis may be another crucial diagnosis related target. However, little is known about LINC00488. To confirm the expression levels of these three lncRNAs, we performed RTqPCR in CRC cell lines. The results were consistent with the in silico analysis results. Additionally, little is known about the functions of IGF2AS, POU6F2 AS2, and LINC00488 in CRC. Thus, additional research is needed to explore the biological and molecular mecha nisms of these DElncRNAs in CRC.
In summary, we analyzed the expression profiles of CRC samples from TCGA and constructed ceRNA networks of the DEGs. KEGG pathway analysis further confirmed the role of these ceRNA networks in the development of CRC. Moreover, we identified several DEGs that were related to clinical prognosis, and the expression of IGF2AS, POU6F2AS2, and LINC00488 was validated using RTqPCR in cell lines. Our study deepens our understanding of ceRNA networks and pro vides potential therapeutic targets and prognosisrelated biomarkers for further research.
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Research background
With the development of high-throughput technology, dysregulation of noncoding genes has been revealed in colorectal cancer (CRC). Furthermore, accumulating studies have demonstrated that long-noncoding RNAs (lncRNAs) function as competing endogenous RNAs (ceRNAs) to regulate oncogene and tumor suppressor gene expression by sponging microRNAs (miRNAs). In the present research, we constructed and analyzed the ceRNA networks and found the prognosis-related differentially expressed genes (DEGs) by bioinformatics 
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Research motivation
CRC is one of the most common malignancies in the world and the prognosis of patients in advanced stage remains poor. Therefore, specific biomarkers and novel therapeutic strategies are urgently required to improve the diagnosis and prognosis for CRC patients.
Research objectives
In our research, we aimed to construct ceRNA networks that include differentially expressed (DE)mRNAs, DElncRNAs, and DEmiRNAs based on co-expression database. Moreover, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and protein-protein interactions network analysis were performed to confirm the importance of ceRNA networks in the development of CRC. Importantly, our study provides new potential lncRNA/ miRNA/mRNA axis for future research and clinical practice.
Research methods
We obtained CRC tissue and normal tissue gene expression profiles from The Cancer Genome Atlas project. DEGs were identified by using the edgeR package in R software. Then, upregulated and downregulated miRNA-centered ceRNA networks were constructed by analyzing the DEGs using multiple bioinformatics approaches. The networks were visualized and mapped using Cytoscape software. DEmRNAs in the ceRNA networks were identified in KEGG pathways using KEGG Orthology Based Annotation System 3.0. KaplanMeier survival analysis was conducted for DEGs and real time quantitative polymerase chain reaction (RT-qPCR) was performed to verify the prognosisassociated DElncRNAs in CRC cell lines.
Research results
We constructed CRC ceRNA networks which included 81 DElncRNAs, 20 DEmiRNAs, and 54 DEmRNAs. KEGG pathway analysis indicated that nine pathways were related to cancer and the most significant pathway was "Colorectal cancer". According to Kaplan-Meier curve analysis, the overall survival was positively associated with five DEGs (IGF2-AS, POU6F2-AS2, hsa-miR-32, hsa-miR-141, and SERPINE1) and it was negatively related to three DEGs (LINC00488, hsa-miR-375, and PHLPP2). The expression of prognosis-related DElncRNAs in CRC cell lines was consistent with the in silico results.
Research conclusions
In the present study, we provide a new pathway to construct ceRNA networks for cancer research and novel insights on non-coding RNAs in CRC. We identified and constructed the ceRNA networks of CRC in large cohorts. Enrichment analysis results verified the critical role of the ceRNA networks in CRC. Besides, multiple prognosis-related DEGs found in this research could be used as potential biomarkers and therapeutic targets.
Research perspectives
Further exploration of ceRNA networks provided a number of potential biomarkers and therapeutic targets for CRC. However, much more work is needed to reveal the function and mechanism of prognosis-related DEGs in the future. The expression of the three long-noncoding RNAs in HT29, LoVo, and SW480 and normal intestinal epithelial cell line NCM460 was detected by RT-qPCR and GAPDH was used as an internal control. a P < 0.01.
